Revolution Medicines, Inc. (RVMD) Executive Team
Revolution Medicines executive team at a glance
Revolution Medicines lists 10 executives, led by Mark A. Goldsmith M.D., Ph.D., CEO, President & Chairman (age 63). Jack Anders is the company's Chief Financial Officer (age 48).
In fiscal year 2025 the highest-paid executive was Mark A. Goldsmith M.D., Ph.D., CEO, President & Chairman, with total pay of $1.71 million. The 5 executives with reported pay received $5.49 million in all.
The average age of the executives with a known age is 55; the youngest is 44 and the oldest 64.
Titles, ages and pay from company filings; pay for fiscal year 2025.
Revolution Medicines, Inc.
Executive Team
Dr. Mark A. Goldsmith M.D., Ph.D.
CEO, President & Chairman
Mr. Jack Anders
Chief Financial Officer
Ms. Margaret A. Horn J.D.
Chief Operating Officer
Mr. Jeffrey Cislini J.D.
Senior VP, General Counsel & Corporate Secretary
Dr. Stephen M. Kelsey FRC Path., FRCP, M.D.
Senior Advisor
Dr. Martin D. Burke M.D., Ph.D.
Co-Founder & Chairman of Scientific Advisory Board
Dr. Michael A. Fischbach Ph.D.
Academic Co-Founder & Member of Scientific Advisory Board
Dr. Kevan M. Shokat Ph.D.
Academic Co-Founder & Member of Scientific Advisory Board
Mr. Walter Reiher Ph.D.
Chief Information Officer
Ms. Jan Smith Ph.D.
Chief Scientific Officer
Revolution Medicines executive pay, fiscal year 2025
| Executive | Title | Age | Total pay |
|---|---|---|---|
| Mark A. Goldsmith M.D., Ph.D. | CEO, President & Chairman | 63 | $1.71 million |
| Stephen M. Kelsey FRC Path., FRCP, M.D. | Senior Advisor | 64 | $1.09 million |
| Margaret A. Horn J.D. | Chief Operating Officer | 62 | $1.02 million |
| Jack Anders | Chief Financial Officer | 48 | $874,133 |
| Jeffrey Cislini J.D. | Senior VP, General Counsel & Corporate Secretary | 50 | $791,750 |
Total pay as reported for the fiscal year; it can include salary, bonus and stock awards.
Questions and answers
Who is the CEO of Revolution Medicines?
Mark A. Goldsmith M.D., Ph.D. (CEO, President & Chairman), age 63; total pay in fiscal year 2025 was $1.71 million.
Who is Revolution Medicines's chief financial officer?
Jack Anders (Chief Financial Officer), age 48.
Who is the highest-paid executive at Revolution Medicines?
Mark A. Goldsmith M.D., Ph.D., CEO, President & Chairman, with total pay of $1.71 million in fiscal year 2025.
Who are Revolution Medicines's top executives?
Mark A. Goldsmith M.D., Ph.D. (CEO, President & Chairman), Jack Anders (Chief Financial Officer), Margaret A. Horn J.D. (Chief Operating Officer), Jeffrey Cislini J.D. (Senior VP, General Counsel & Corporate Secretary) and Stephen M. Kelsey FRC Path., FRCP, M.D. (Senior Advisor), and 5 more.
